Your browser doesn't support javascript.
loading
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.
Payne, Ruth O; Silk, Sarah E; Elias, Sean C; Miura, Kazutoyo; Diouf, Ababacar; Galaway, Francis; de Graaf, Hans; Brendish, Nathan J; Poulton, Ian D; Griffiths, Oliver J; Edwards, Nick J; Jin, Jing; Labbé, Geneviève M; Alanine, Daniel Gw; Siani, Loredana; Di Marco, Stefania; Roberts, Rachel; Green, Nicky; Berrie, Eleanor; Ishizuka, Andrew S; Nielsen, Carolyn M; Bardelli, Martino; Partey, Frederica D; Ofori, Michael F; Barfod, Lea; Wambua, Juliana; Murungi, Linda M; Osier, Faith H; Biswas, Sumi; McCarthy, James S; Minassian, Angela M; Ashfield, Rebecca; Viebig, Nicola K; Nugent, Fay L; Douglas, Alexander D; Vekemans, Johan; Wright, Gavin J; Faust, Saul N; Hill, Adrian Vs; Long, Carole A; Lawrie, Alison M; Draper, Simon J.
Afiliación
  • Payne RO; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Silk SE; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Elias SC; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Miura K; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Diouf A; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Galaway F; Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • de Graaf H; NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Brendish NJ; NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Poulton ID; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Griffiths OJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Jin J; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Labbé GM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Alanine DG; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Siani L; ReiThera SRL (formerly Okairos SRL), Viale Città d'Europa, Rome, Italy.
  • Di Marco S; ReiThera SRL (formerly Okairos SRL), Viale Città d'Europa, Rome, Italy.
  • Roberts R; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Green N; Clinical Biomanufacturing Facility, University of Oxford, Oxford, United Kingdom.
  • Berrie E; Clinical Biomanufacturing Facility, University of Oxford, Oxford, United Kingdom.
  • Ishizuka AS; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Nielsen CM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Bardelli M; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Partey FD; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Ofori MF; Centre for Medical Parasitology, Department of Immunology and Microbiology (ISIM), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Barfod L; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
  • Wambua J; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
  • Murungi LM; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Osier FH; KEMRI Centre for Geographic Medicine Research, Kilifi, Kenya.
  • Biswas S; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • McCarthy JS; KEMRI Centre for Geographic Medicine Research, Kilifi, Kenya.
  • Minassian AM; KEMRI Centre for Geographic Medicine Research, Kilifi, Kenya.
  • Ashfield R; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Viebig NK; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Nugent FL; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Douglas AD; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Vekemans J; European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Heidelberg, Germany.
  • Wright GJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Faust SN; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Hill AV; GSK Vaccines, Wavre, Belgium.
  • Long CA; Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Lawrie AM; NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Draper SJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
JCI Insight ; 2(21)2017 11 02.
Article en En | MEDLINE | ID: mdl-29093263
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Proteínas Protozoarias / Vacunación / Malaria Falciparum / Anticuerpos Neutralizantes Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Proteínas Protozoarias / Vacunación / Malaria Falciparum / Anticuerpos Neutralizantes Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido